Clinical Trial Update: Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating intensive rosuvastatin treatment around PCI in Chinese patients with non-ST-elevation acute coronary syndrome; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Non-ST-elevation Acute Coronary Syndromes | Phase 4 | Status: UNKNOWN